Page last updated: 2024-09-04

n-(1-carboxyethyl)-alpha-(2-phenylethyl)glycyl-leucine, n-phenylamide and Disease Models, Animal

n-(1-carboxyethyl)-alpha-(2-phenylethyl)glycyl-leucine, n-phenylamide has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axel, MG; Becker, JW; Bugianesi, RL; Caldwell, CG; Chapman, KT; Christen, AJ; Durette, PL; Esser, CK; Girotra, NN; Hagmann, WK; Harrison, RK; Kopka, IE; Lanza, TJ; Levorse, DA; MacCoss, M; Marcy, AI; McDonnell, J; Moore, VL; Niedzwiecki, L; Olszewski, JM; Owens, KA; Ponpipom, MM; Saphos, C; Simeone, JP; Visco, DM1

Other Studies

1 other study(ies) available for n-(1-carboxyethyl)-alpha-(2-phenylethyl)glycyl-leucine, n-phenylamide and Disease Models, Animal

ArticleYear
Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
    Journal of medicinal chemistry, 1997, Mar-14, Volume: 40, Issue:6

    Topics: Animals; Arthritis; Binding Sites; Cartilage; Crystallography, X-Ray; Dipeptides; Disease Models, Animal; Gelatinases; Interleukin-1; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Mice; Models, Molecular; Molecular Structure; Protease Inhibitors; Rabbits; Rats; Recombinant Proteins; Structure-Activity Relationship; Transferrin; Zinc

1997